Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT03537443 |
Date of registration:
|
15/05/2018 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Bone and Muscle Health in Kids
BONUSKids |
Scientific title:
|
Effect of Maternal Vitamin D Supplementation During Pregnancy on Offspring Bone Mass, Body Composition and Muscle Strength in Early Childhood: Follow-up of a Randomized Controlled Trial Cohort. |
Date of first enrolment:
|
October 21, 2018 |
Target sample size:
|
642 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT03537443 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Bangladesh
| | | | | | | |
Contacts
|
Name:
|
Daniel Roth, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
The Hospital for Sick Children |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
The sample population will be drawn from a cohort registry of mother-infant pairs who
participated in the recently-completed Maternal Vitamin D for Infant Growth (MDIG)
randomized controlled trial (NCT01924013):
- Child is available for participation at 45 to 51 months postnatal age
- Mother received =80% of assigned prenatal vitamin D or placebo doses during the MDIG
trial
- Child and primary caregiver(s) reside in Dhaka, Bangladesh or nearby regions
- A parent/guardian provides written or thumb-print informed consent for study
procedures
Exclusion Criteria:
- Mother participated in the MDIG trial but chose not to be included in the cohort
registry for contact regarding follow-up studies
- Children outside the eligible age range (aged below 45 months or above 51 months)
- Child is diagnosed with any developmental disorder that would render difficulty in
completion of the DXA scan (e.g. Autism)
- Child is unable to bear weight on his/her legs (e.g. wheelchair bound)
- Child has a current fracture or break in which his/her limb is supported by an
orthopedic cast
Age minimum:
45 Months
Age maximum:
51 Months
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Skeletal Disorder
|
Intervention(s)
|
Dietary Supplement: Cholecalciferol (vitamin D3)
|
Primary Outcome(s)
|
Total-body-less head bone mineral content and total-body-less head bone mineral density
[Time Frame: 4 years of age]
|
Secondary Outcome(s)
|
Head bone mineral content and head bone mineral density
[Time Frame: 4 years of age]
|
Total-body-less head lean and total-body-less head fat mass
[Time Frame: 4 years of age]
|
Whole-body lean and whole-body fat mass
[Time Frame: 4 years of age]
|
Muscle function (handgrip strength)
[Time Frame: 4 years of age]
|
Whole-body (including head) bone mineral content and whole-body bone mineral density
[Time Frame: 4 years of age]
|
Secondary ID(s)
|
1000060961
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|